Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Boeing
BA
|
+$936M |
| 2 |
Amazon
AMZN
|
+$702M |
| 3 |
UnitedHealth
UNH
|
+$685M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$674M |
| 5 |
Bank of America
BAC
|
+$633M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$536M |
| 3 |
Tesla
TSLA
|
+$509M |
| 4 |
Citigroup
C
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$434M |
Sector Composition
| 1 | Healthcare | 16.72% |
| 2 | Technology | 15.86% |
| 3 | Financials | 11.72% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5476
Willamette Valley Vineyards
WVVI
$24.8M
| $39.3K | ﹤0.01% |
+11,726
| New | +$39.3K |
|
|
ADAM
5477
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $39K | ﹤0.01% |
6,437
-29,485
| -82% | -$179K |
|
5478
Vasta Platform
VSTA
$364M
| $38.9K | ﹤0.01% |
19,448
-2,906
| -13% | -$5.81K |
|
5479
Sabre
SABR
$738M
| $38.8K | ﹤0.01% |
10,637
-1,457,378
| -99% | -$5.32M |
|
5480
CNS Pharmaceuticals
CNSP
$4.25M
| $38.8K | ﹤0.01% |
+536
| New | +$38.8K |
|
5481
Xilio Therapeutics
XLO
$38.2M
| $38.5K | ﹤0.01% |
+40,316
| New | +$38.5K |
|
|
PHLT
5482
Performant Healthcare, Inc. Common Stock
PHLT
$607M
| $38.4K | ﹤0.01% |
12,709
-38,453
| -75% | -$116K |
|
5483
Urban One Class A
UONE
$63.1M
| $37.9K | ﹤0.01% |
+24,609
| New | +$37.9K |
|
5484
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$5.69M
| $37.6K | ﹤0.01% |
+2,074
| New | +$37.6K |
|
5485
Iterum Therapeutics
ITRM
$30.5M
| $37.5K | ﹤0.01% |
+21,207
| New | +$37.5K |
|
5486
SPDR Portfolio S&P 500 Growth ETF
SPYG
$41.7B
| $37.4K | ﹤0.01% |
426
-24,457
| -98% | -$2.15M |
|
5487
Good Times Restaurants
GTIM
$17.1M
| $37.2K | ﹤0.01% |
14,357
-3,933
| -22% | -$10.2K |
|
5488
Tharimmune
THAR
$16.8M
| $37.1K | ﹤0.01% |
+18,129
| New | +$37.1K |
|
|
KUKE
5489
Kuke Music
KUKE
$44.8M
| $37K | ﹤0.01% |
+9,382
| New | +$37K |
|
5490
MicroSectors FANG+ ETNs due Jan 8 2038
FNGS
$520M
| $36.9K | ﹤0.01% |
644
-4,772
| -88% | -$274K |
|
5491
LM Funding America
LMFA
$19.3M
| $36.9K | ﹤0.01% |
17,171
-17,743
| -51% | -$38.1K |
|
5492
Netcapital
NCPL
$11M
| $36.8K | ﹤0.01% |
17,705
-317
| -2% | -$659 |
|
5493
Reborn Coffee
REBN
$13.4M
| $36.8K | ﹤0.01% |
22,177
+5,554
| +33% | +$9.22K |
|
|
PIM
5494
Putnam Master Intermediate Income Trust
PIM
$169M
| $36.5K | ﹤0.01% |
+11,185
| New | +$36.5K |
|
5495
OLB
OLB
$11M
| $36.4K | ﹤0.01% |
+17,608
| New | +$36.4K |
|
5496
MidCap Financial Investment
MFIC
$1.16B
| $36.4K | ﹤0.01% |
+2,695
| New | +$36.4K |
|
|
TSVT
5497
DELISTED
2seventy bio
TSVT
| $36.2K | ﹤0.01% |
12,318
+12,201
| +10,428% | +$35.9K |
|
|
YYGH
5498
YY Group Holding Ltd
YYGH
$22.2M
| $36.2K | ﹤0.01% |
19,146
+4,318
| +29% | +$8.16K |
|
5499
Natural Health Trends
NHTC
$53.9M
| $36.1K | ﹤0.01% |
7,820
+1,945
| +33% | +$8.99K |
|
5500
Invesco India ETF
PIN
$212M
| $36.1K | ﹤0.01% |
1,401
-4,586
| -77% | -$118K |
|